公开(公告)号：US20240252575A1

公开(公告)日：2024-08-01

申请号：US18043829

申请日：2021-09-03

申请人： Forward Science Technologies, LLC

发明人： Brian Pikkula ,  Katherine R. Adkins ,  Robert J. Whitman ,  Kathleen O. Hotze

IPC分类号： A61K36/54 ,  A61K9/00 ,  A61K9/06 ,  A61K36/53 ,  A61K36/61 ,  A61K36/906 ,  A61K47/02 ,  A61K47/36 ,  A61P17/02

CPC分类号： A61K36/54 ,  A61K9/006 ,  A61K9/06 ,  A61K36/53 ,  A61K36/61 ,  A61K36/906 ,  A61K47/02 ,  A61K47/36 ,  A61P17/02

摘要： The invention provides a composition in the form of a hydrogel useful for treating wounds in the oral cavity. The hydrogel includes one or more polysaccharides, one or more polyols, one or more essential oils, and water, and has a pH of from about 6.2 to about 8.5. The invention also provides a method of treating a wound in the oral cavity by applying an effective amount of the composition to the wound.

公开(公告)号：US12048712B2

公开(公告)日：2024-07-30

申请号：US18381558

申请日：2023-10-18

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A61K36/00 ,  A61K31/235 ,  A61K31/7076 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

摘要： Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US20240216455A1

公开(公告)日：2024-07-04

申请号：US17916806

申请日：2021-07-23

申请人： ANUPAM GUPTA

发明人： ANUPAM GUPTA

IPC分类号： A61K36/31 ,  A61K9/00 ,  A61K33/04 ,  A61K33/14 ,  A61K33/42 ,  A61K36/54 ,  A61K36/9066

CPC分类号： A61K36/31 ,  A61K9/0014 ,  A61K33/04 ,  A61K33/14 ,  A61K33/42 ,  A61K36/54 ,  A61K36/9066

摘要： The embodiments relate to a non-steroidal topical formulation comprising 10 wt % to 20 wt % of an active ingredient consisting of a combination of group I and group II component and 80 wt % to 90 wt % of inactive ingredient comprising one or more pharmaceutically acceptable excipient. The group I component maybe a plant extract obtained from Curcuma spp, Litsea spp., and Lepidium spp. and group II component may be selected from a group comprising Potassium sulfate (Kali sulphuricum), Potassium Phosphate (Kali phosphoricum), Sodium sulfate (Natrum sulphuricum, Sodium chloride (Natrum phosphoricum), Potassium Chloride (Kali muriaticum), and Sodium Phosphate (Natrum phosphoricum). The said formulation is capable of efficiently eliminating or reducing age-related osteoarthritic joint pain, inflammation and musculoskeletal diseases and provides long-term relief to the aged patients. Another preferred embodiment of the present invention relates to a method of preparing the said formulation.

公开(公告)号：US20240197804A1

公开(公告)日：2024-06-20

申请号：US18287342

申请日：2022-04-22

申请人： LABORATOIRE AROMA SCIENCE

发明人： Laurent MOY

IPC分类号： A61K36/61 ,  A61K36/28 ,  A61K36/324 ,  A61K36/54 ,  A61K36/835 ,  A61K36/8905 ,  A61P25/28

CPC分类号： A61K36/61 ,  A61K36/28 ,  A61K36/324 ,  A61K36/54 ,  A61K36/835 ,  A61K36/8905 ,  A61P25/28

摘要： The present invention relates to the pharmaceutical and nutraceutical fields and, more specifically, to a composition comprising an extract from a combination of plants for the prevention and/or treatment of a neurodegenerative disease

公开(公告)号：US20240197650A1

公开(公告)日：2024-06-20

申请号：US18288840

申请日：2022-06-28

申请人： TARGETING GUT DISEASE SRL

发明人： Maria Chiara VALERII

IPC分类号： A61K31/11 ,  A61K31/085 ,  A61K36/54 ,  A61K36/61 ,  A61P31/10

CPC分类号： A61K31/11 ,  A61K31/085 ,  A61K36/54 ,  A61K36/61 ,  A61P31/10

摘要： A combination of active ingredients of plant origin or synthetic analogues or extracts of plant origin containing cinnamaldheyde and eugenol or derivatives thereof, useful as antimycotic for both human and veterinary therapeutic use, mainly against fungal infections caused by Candida. Compositions containing the combination for topical or systemic administration are also described.

公开(公告)号：US20240122958A1

公开(公告)日：2024-04-18

申请号：US18381558

申请日：2023-10-18

申请人： Bonafide Health, LLC

发明人： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC分类号： A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

摘要： Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US11957725B2

公开(公告)日：2024-04-16

申请号：US17714236

申请日：2022-04-06

申请人： Lisa Geng

发明人： Lisa Geng

IPC分类号： A61K36/185 ,  A23L27/10 ,  A23L27/12 ,  A23L33/00 ,  A23L33/105 ,  A23L33/12 ,  A61K31/07 ,  A61K31/197 ,  A61K31/198 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/20 ,  A61K36/24 ,  A61K36/27 ,  A61K36/328 ,  A61K36/54 ,  A61K36/81 ,  A61K36/82 ,  A61K36/9066 ,  A61P25/28

CPC分类号： A61K36/185 ,  A23L27/10 ,  A23L27/12 ,  A23L33/105 ,  A23L33/12 ,  A23L33/30 ,  A61K31/07 ,  A61K31/197 ,  A61K31/198 ,  A61K31/202 ,  A61K31/205 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K35/20 ,  A61K36/24 ,  A61K36/27 ,  A61K36/328 ,  A61K36/54 ,  A61K36/81 ,  A61K36/82 ,  A61K36/9066 ,  A61P25/28 ,  A23V2002/00 ,  A61K36/185 ,  A61K2300/00 ,  A61K36/27 ,  A61K2300/00 ,  A61K36/328 ,  A61K2300/00 ,  A61K36/54 ,  A61K2300/00 ,  A61K36/81 ,  A61K2300/00 ,  A61K36/82 ,  A61K2300/00 ,  A61K36/9066 ,  A61K2300/00 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/21

摘要： Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.

公开(公告)号：US20240091137A1

公开(公告)日：2024-03-21

申请号：US17945404

申请日：2022-09-15

申请人： Valerie Marie Gregory

发明人： Valerie Marie Gregory

IPC分类号： A61K9/00 ,  A61K31/19 ,  A61K36/54 ,  A61K36/752 ,  A61K47/10

CPC分类号： A61K9/0014 ,  A61K31/19 ,  A61K36/54 ,  A61K36/752 ,  A61K47/10

摘要： WellMed is a topical analgesic spray applied to an affected area of the body for pain relief, with no known side effects. It contains all natural ingredients and therefore is a green medication. Because the medication is not taken by mouth, it bypasses the body's metabolism for amore targeted form of pain relief.

公开(公告)号：US11904047B1

公开(公告)日：2024-02-20

申请号：US17648845

申请日：2022-01-25

申请人： Sandie Tran ,  Sang Nguyen

发明人： Sandie Tran ,  Sang Nguyen

IPC分类号： A61K9/00 ,  A61K36/9066 ,  A61K9/68 ,  A61K31/165 ,  A61K36/185 ,  A61K36/61 ,  A61K36/54 ,  A61K36/906 ,  A23L33/105 ,  A61K36/81 ,  A61K45/06 ,  A61K36/9068

CPC分类号： A61K9/0056 ,  A23L33/105 ,  A61K9/0058 ,  A61K31/165 ,  A61K36/185 ,  A61K36/54 ,  A61K36/61 ,  A61K36/81 ,  A61K36/906 ,  A61K36/9066 ,  A61K36/9068 ,  A61K45/06

摘要： An herbal composition includes a plurality of herbal components designed to work harmoniously together to alleviate pain and reduce inflammation of the oral mucosa. Such pain and inflammation may be associated with, for example, recurrent aphthous stomatitis. The formulation can include ginger, cayenne, cloves, cinnamon, turmeric, and annatto. The herbal composition may be formulated as a candy or gum, for example, to provide effective delivery to the oral mucosa.

公开(公告)号：US20240041966A1

公开(公告)日：2024-02-08

申请号：US18258639

申请日：2021-12-22

申请人： DiaBliss Consumer Products Pvt Ltd

发明人： Vr. RAMANATHAN ,  Siva VALLABHANENI ,  V. RAJALAKSHMI

IPC分类号： A61K36/54 ,  A61K36/71 ,  A61K36/9066 ,  A61K36/9068 ,  A61K36/61 ,  A61K36/55 ,  A61K36/484 ,  A61K36/235 ,  A61P9/12

CPC分类号： A61K36/54 ,  A61K36/71 ,  A61K36/9066 ,  A61K36/9068 ,  A61K36/61 ,  A61K36/55 ,  A61K36/484 ,  A61K36/235 ,  A61P9/12

摘要： Nutraceutical formulations, used for prevention, cure, treatment and/or management of hypertension and/or associated condition(s), with enhanced organoleptic properties as monotherapy, combination and/or dual therapy. The formulations have elements of biological origin more particularly a herbal formulation(s).